@AHS I guess we will have to put up with renewed talk of mega deals and partnerships and networking and showcasing and blah blah blah as ASCO 2024 inches closer.
As a recap, prior to the 2023 ASCO @antibotter told the forum:
”It is a forgone conclusion Starpharma will be presenting Dep Docetaxel/Cabazitaxel/Irinotecan Phase 2 clinical data results at this event”
I unsuccessfully asked multiple times for a retraction as there was zero evidence for this statement to be factual, was just guess work and was IMO leaning towards ramping and influencing less experienced investors.
Six days later, at the end of ASCO 2023:
‘Well it does not look like there will be any formal abstracts presented by Starpharma on a podium at the ASCO conference 2023’ ~ @antibotter
Go figure!
@AHS I guess we will have to put up with renewed talk of mega...
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
-0.005(4.35%) |
Mkt cap ! $45.32M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 11.5¢ | 11.0¢ | $70.99K | 620.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 337138 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 116759 | 6 |
View Market Depth
| Last trade - 16.10pm 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
11.5¢ |
Change
-0.005 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 11.5¢ | 11.5¢ | 11.0¢ | 165069 | ||
| Last updated 15.30pm 17/05/2024 ? | |||||
| SPL (ASX) Chart |